Aptus Pharma Ltd. Press Release May 13 2026

The Exchange has received the disclosure under Regulation 29(1) / 2(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tejash Hathi

View Attachment